Close look in EMT, MAPK and inflammation: what differs in mouse embryonic stem, somatic and cancer cells?

Journal Title: Dokuz Eylul Universitesi Tip Fakultesi Dergisi - Year 2018, Vol 32, Issue 3

Abstract

INTRODUCTION: Life is a continuous cycle of the cells, composed of beginning, surviving and death. Cells keep dividing, differentiate and turn into somatic cells. The somatic cells at some point can give way to cancer cells and share characteristics of stem cells. The processes during these periods are important for the identifying the tendency to abnormality in somatic cells and transformation to the cancer cells. To control emergence and progress of the cancer, mechanisms take part in the surviving become significant, especially EMT and inflammation. EMT occurs in both embryonic developmental stages and cancer progression and molecular basis of this process can be the therapeutic target for cure METHODS: For cancer representation mouse squamous lung cancer cells (SqLCCs), for somatic origin mouse skin fibroblasts (MSFs) and for embryonic stem cell mouse embryonic stem cells (mESCs) were used for comparison of three signalling pathways (EMT, MAPK and inflammation) at the gene expression level. Immunofluorescence staining protein levels of ERK 1/2, Vimentin and Twist were compared RESULTS: ERK1/2 protein expression similar in MSFs and SqLCCs while mESCs expression wasthe lowest. Besides, Twist and Vimentin expression statistically different in three. According to gene expression profiling of the EMT and inflammation supported by the MAPK signalling pathway are a far cry from each other at prominent genes especially Sparc, Vimentin, Mapksp1 and Il24 DISCUSSION AND CONCLUSION: According to the results, three different cell linages showed different pattern both in gene and protein expression. Therefore, these moleculescan be the potential driving force for therapeutic target.

Authors and Affiliations

Fatih OLTULU, Berrin Özdil, Çevik Gürel, Eda Açıkgöz, duygu çalık kocatürk, Yasemin Adalı, Ayşegül UYSAL, Gülperi ÖKTEM, Hüseyin AKTUĞ

Keywords

Related Articles

Subureteric injection in the treatment of vesicoureteral reflux: Single center experience

INTRODUCTION: Subureteric agent injection is preferred increasingly in the treatment of vesico-ureteral reflux (VUR) disease. In this study, we aimed to evaluate the long term results of patients who had VUR disease trea...

Assessment of individual earthquake preparedness levels of health disaster workers: UMKE (National Medical Rescue Teams) Association as an example

Objective: Disasters are considered as an important public health problem. Among natural hazards, earthquake are responsible for higher number of injured and dead. Health workers, especially disaster health workers could...

Lokal İleri Rektum Kanseri Hastalarında Neoadjuvan Tedavi Öncesi Serum Karsinoembriyonik Antijen Düzeylerinin Neoadjuvan Tedaviye Yanıtı Öngördürücülüğü

Amaç: Çalışmamızda lokal ileri evre rektum kanseri tanısı alan hastalarda, neoadjuvan tedavi öncesi serum Karsionoembriyonik Antijen (CEA) düzeyleri ile neoadjuvan tedaviye yanıt ölçütleri arasındaki birlikteliği değerle...

Over Torsion And Ovaryopecsis In Pregnancy

A patient, aged 28 years and 33 weeks of pregnancy, admitted to our center with severe left lower quadrant pain. Torsion 9 cm left overcyst was prediagnosed. The patient underwent general anesthesia and was corrected for...

Effects of locally applied clinoptilolite (Froximun®) on seroma formation in a rat mastectomy and axillary lymph node dissection model

Objective: Seroma formation is one of the most frequent complications following breast cancer surgery. Although many techniques and drugs have been investigated, no definitive data are available concerning how to prevent...

Download PDF file
  • EP ID EP440711
  • DOI 10.5505/deutfd.2018.16768
  • Views 79
  • Downloads 0

How To Cite

Fatih OLTULU, Berrin Özdil, Çevik Gürel, Eda Açıkgöz, duygu çalık kocatürk, Yasemin Adalı, Ayşegül UYSAL, Gülperi ÖKTEM, Hüseyin AKTUĞ (2018). Close look in EMT, MAPK and inflammation: what differs in mouse embryonic stem, somatic and cancer cells?. Dokuz Eylul Universitesi Tip Fakultesi Dergisi, 32(3), 201-212. https://europub.co.uk/articles/-A-440711